By Ashley Yeo / November 26, 2012
Forty-two percent of otoplasties performed in the US are for people under the age of 18 years. Elective plastic surgery in teens has long been a source of controversy, posing ethical and societal questions. But there are conflicting views on whether case numbers are actually rising. Ashley Yeo reports
By Ashley Yeo / October 15, 2012
The US is the ‘heaviest’ nation globally, but also high up the list are European countries: Croatia, Greece, Russia, Germany and the UK, which is Western Europe’s fattest country. This might explain the popularity of weight-loss websites among UK clickers and the hold that weight-loss procedures — surgical or otherwise — have on the public in general. Ashley Yeo reports
By Ashley Yeo / September 2, 2012
Plastic surgery is not all about privately-funded elective procedures, as the example of breast reconstruction after a mastectomy shows. This particular procedure also suffers low awareness levels, but new — and new age — initiatives are helping bring it out into the open. Ashley Yeo reports
By Ashley Yeo / July 15, 2012
Crisis management it may be, but the EU is working hard in the wake of the PIP scandal to get its house in order as far as cosmetic surgery regulation and standard-setting are concerned. Opinion is divided as to the best course to take, but the consensus now is that the opportunity to establish a regulatory basis must not be missed. Ashley Yeo reports
By Ashley Yeo / June 1, 2012
A US consumer survey indicates that anti-ageing cosmetic procedures are the province of the wealthy. Ashley Yeo suggests that this is too narrow a view
By Ashley Yeo / April 15, 2012
Breast implants have been the focus of much attention recently, mainly for the wrong reasons. But confidence in the market remains high, as 2011 procedure volumes in the UK and US show. The UK’s BAAPS president‑elect, Rajiv Grover, and the US ASPS president, Malcolm Roth, give their views on general business trends to Ashley Yeo
By Ashley Yeo / March 1, 2012
The fungal nail market, worth $1 billion globally, has been under-served — and for clear reasons, says Moberg Derma CEO, president and co-founder Peter Wolpert. With new technologies and an original business model, the Swedish company aims to change that, he tells Ashley Yeo